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Background
Brazil is a country of large numbers: it is a continental size country, the fifth most popu-
lous country in the world (United Nations Population Found 2010) and one of the world’s 
richest countries in biodiversity terms (Mittermeier et al. 2005). Brazil occupied the sev-
enth position in the ranking of world’s largest economies in 2013 (Centre for Economics 
and Business Research 2013). Despite of the above, Brazil’s exports are mainly composed 
of non-industrial or low-technological goods. In 2010, the commodities accounted for 
51 % of Brazil’s exports, representing around 5 % of all commodities traded in the world. 
In parallel, Brazil’s contribution to the global exportation of high-technological goods 
was of around 0.5 % in the same period (Em discussão! Revista de Audiências Públicas 
do Senado Federal 2012).
Besides affecting the Brazilian trade balance, this scenario causes a high technological 
dependence that reaches several areas, including the biotechnology sector. Even though 
the significant growth of this sector in Brazil is worldwide recognized (Nature Editorial 
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2010; Resende 2012), studies involving Brazilian biotech companies showed that 86 % of 
them depend on imported goods and services (BRBiotec Brazil 2011). Enzyme technol-
ogy is a subfield of biotechnology where new processes have been and are being devel-
oped to manufacture both bulk and high added-value products utilizing enzymes as 
biocatalysts. Food, fine chemicals, pharmaceuticals and biofuels are examples of prod-
ucts manufactured using enzymes. This kind of catalyst are also used to provide services, 
as in washing and environmental processes, or for analytical and diagnostic purposes 
(Buchholz et al. 2012).
Enzymes are an important branch of biotechnology market, and the world demand 
on several enzymes is expected to rise 6.3 % annually to U$7 billion in 2017, with Latin 
America being responsible for a significant percentage of such consumption (Freedo-
nia Group 2014). Considering the rising economic importance of enzyme technology, 
the present article analyzes the Brazilian trade balance of enzyme-related goods and 
discusses such data in terms of the Brazilian scientific community, which discussion is 
further corroborated with bibliometric studies, aiming at answering the following ques-
tions: If Brazil’s biotechnological potential is high, why is the enzyme market so in defi-
cit? Has Brazil enough technical staff for developing enzyme technologies?
Methods
Trade balance
Data from 1996 to 2013 have been collected from AliceWeb, a public online database 
developed by the Brazilian Ministry of Development, Industry and Foreign Trade 
(MDIC). All data related to imported and exported goods are classified in accordance 
with the Mercosur Common Nomenclature (MCN), which was adopted by Brazil, 
Argentina, Paraguay and Uruguay in 1995. The MCN codes comprise eight digits, the 
first six being formed by the Harmonized System (an international standardized system 
of names and numbers to classify traded goods) and the last two being specific to the 
Mercosur context. Thirty-one MCN codes have been selected as being directed to an 
enzyme itself or an enzyme-containing product. Three of them (30029010, 38220010 
and 38220090) have an unclear description and were partially included in the present 
study as they may encompass enzyme-containing products. The selected MCN codes are 
listed in Table 1.
Research
Statistic analyses on the number of master’s and doctoral degrees granted by December 
2013 in Brazil were made based on data obtained at the National Council for Scientific 
and Technological Development (CNPq) website (www.cnpq.br). Information on the 
number of researches involved in areas related to enzyme technology and their scien-
tific production were collected at the same website, by searching for keywords in the 
researchers’ online curriculum (lattes.cnpq.br).
Bibliometric studies
Searches for scientific publications and patent documents from 1983 to 2012 were per-
formed respectively using the platforms Web of Science and Orbit.com. The searches 
were carried out to four important industrial sectors that employ lipases—kinetic 
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resolution, production of detergents, food and feed and biodiesel—using the search 
strategies disclosed in Tables 2 and 3.
The data obtained from these searches also resulted in a study that aimed at evaluating 
the biotechnological interest towards lipases, which study was published by our research 
group in the journal Plos One, in 2015 (Daiha et al. 2015).
Results and discussion
Trade balance
The evolution of Brazilian trade balance in the enzyme technology field has been ana-
lyzed in terms of the value and volume of the goods imported and exported by the coun-
try. In both cases, it is verified a growing trade deficit through the period of analysis, 
which profile may be related to the fact that Brazil’s imports are increasing at a signifi-
cant higher rate when compared to the exports (Fig. 1).
Table 1 Mercosur Common Nomenclature (MCN) codes and their respective description
a MCNs which descriptions are unclear regarding the inclusion of enzyme-containing products
MCN codes Products
23099060 Preparations with xylanase and Beta-Glucanase, supplemented with wheat bran
30021032 Plasmin (Fibrolysin)
30021033 Urokinase
30029010 Diagnostic reagents of microbial origina
30039021 Drug containing streptokinase, except in doses
30039022 Drug containing l-asparaginase, except in doses
30039023 Drug containing deoxyribonuclease, except in doses
30039029 Drugs with other enzymes, without vitamins, etc., except in doses
30049011 Drug containing Streptokinase, in doses
30049012 Drug containing l-asparaginase, in doses
30049013 Drug containing deoxyribonuclease, in doses
30049019 Drug containing other enzymes in doses
32029030 Enzymatic preparations for pre-tanning
35071000 Rennet and its concentrates
35079011 Alfa-amylase (Aspergillusoryzae)





35079025 Mixture of streptokinase and streptodornase
35079026 Papain
35079029 Other proteases and their concentrates
35079031 Lysozymeand its hydrochloride
35079032 l-asparaginase
35079039 Other enzymes and their concentrates
35079041 Cellulase-based enzymes
35079042 Transglutaminase-based enzymes
35079049 Other prepared enzymes
38220010 Reagents for determination of blood or urine composition, paper support, etc.a
38220090 Other diagnostic or laboratory reagentsa
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Such difference between imports and exports is more significant when the analysis is 
performed considering the value of the goods (Fig. 1a). This is so since Brazil’s exports 
are mainly characterized by low value-added goods, whilst the country depends on high 
value-added goods produced abroad.
Another indicative of the low value-added of the goods included in the enzyme tech-
nology field exported by Brazil is the comparison between the percentage of exports in 
USD and tons (Fig. 2). In the period of analysis, the percentages of exports measured by 
value and volume are of around 14 and 40 % respectively. This fact indicates that Brazil 
import more added value goods when compared with the exported goods.
Comparing Brazil’s biotechnology potential expressed by its great biodiversity found 
in many biomes (e.g. Amazon Forest, Cerrado, Atlantic Forest, and others) with Brazil’s 
Table 2 Patent search strategies set up for each of the four applications of lipase
“?” is a truncation symbol replacing zero or one character; “+” is a truncation symbol representing any number of characters; 
“_” is an operator indicating that two terms may be connected in a single word or separated in two adjacent words; “W” is 
an operator indicating that the adjacent terms are in the order specified; “S” is an operator indicating that the terms are in 
the same sequence. /BI: the terms were searched in the title and abstract of the patent documents; /IC: international patent 
classification; EPRD: first priority date of the patent family
Lipase application Search strategy
Kinetic resolution ((((LIPASE?)/BI AND (ENANTIO+ OR STEREO_SELECTIV+ OR (OPTIC+ W 
(ACTIV+ OR PUR+ OR ISOMER+)) OR RESOLUTION OR ((SPLIT+ OR 
SEPARAT+ OR RESOLV+ OR ESTERIF+) S (CHIRAL+ OR RACEM+)))/
BI AND (C12P OR C07C OR C07D OR C12R OR C12N)/IC) NOT (LIPASE S 
(INHIBITOR+ OR MODULAT+ OR DEFICIENCY))/BI)) AND (EPRD = 1983-
01-01:2012-12-31)
Production of detergents (((LIPASE?)/BI AND (DETERGENT? OR +WASH+ OR LAUND+ OR 
BLEACH+ OR CLEAN+ OR SOAP+)/BI) AND (C11D OR C12N)/IC) AND 
(EPRD = 1983-01-01:2012-12-31)
Production of food and  
feed products
((((LIPASE?)/BI AND (FOOD+ OR FEED+ OR JUICE OR BEVERAGE+ OR 
FISH OR DOUGH OR MILK+ OR CHEESE+ OR BUTTER+ OR MEAT OR 
EGG OR YOLK OR BREAD))/BI) NOT ((INHIBITOR+) S LIPASE/BI)) AND 
(A23+ OR A21+ OR C12N)/IPC AND (EPRD = 1983-01-01:2012-12-31)
Production of biodiesel (((LIPASE?)/BI AND ((+FUEL? OR +DIESEL?) OR (FATTY ACID W (METHYL 
OR ALKYL) W ESTER?) OR FAME OR FAAE)/BI) AND (C12P OR C10L OR 
C12N OR C11C OR C10G)/IC) AND (EPRD = 1983-01-01:2012-12-31)
Table 3 Publication search strategies set up for each of the four applications of lipase
“*” is a truncation symbol replacing any number of characters; “$” is a truncation symbol replacing zero or one character; 
“NEAR/n” is an operator indicating that two terms are within n words of each other
Lipase application Search strategy
Kinetic resolution TITLE:(LIPASE$) AND TOPIC((KINETIC OR CHIRAL OR LIPASE OR HYDROLY-
SIS OR ENZYMATIC) NEAR/1 RESOLUTION) AND PUBLICATION 
YEARS:(1983–2012)
Production of detergents TITLE:(LIPASE$) AND TOPIC(*DETERGENT$ OR LAUNDR* OR DISH* 
OR ((REMOV* OR CLEAN* OR WASH*) NEAR/1 (STAIN* OR OIL$ OR 
GREASE OR FAT* OR TRIGLYCERIDE$ OR SOIL$))) AND PUBLICATION 
YEARS:(1983–2012)
Production of food and feed products TOPIC:(LIPASE* AND (((FOOD* OR FEED) NEAR/5 (INDUSTR* OR FORMU-
LATION* OR PRODUCT*)) OR (CHEESE* NEAR/1 (RIPENING OR FLAVOR* 
OR MAKING OR PRODUCT*)) OR ((BUTTER OR MILK) NEAR/0 (EQUIVA-
LENT* OR SUBSTITUTE*)) OR “DAIRY PRODUCT*” OR DOUGH*)) AND 
PUBLICATION YEARS: (1983–2012)
Production of biodiesel TITLE:(LIPASE$) AND TOPIC(BIODIESEL OR DIESEL OR BIOFUEL$ OR FUEL$) 
AND PUBLICATION YEARS: (1983–2012)
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trade balance deficit the contradiction is visible. Why Brazil has one of the most impor-
tant biodiversity of the world but has a negative trade balance in enzyme market? Could 
the trade balance deficit be explained by a deficit in technical staff? In order to answer 
these questions the researcher community in Brazil has been analyzed using data 
obtained at the National Council for Scientific and Technological Development (CNPq)’s 
database.
Research community
According to data provided at CNPq’s website, by December 2013 Brazilian post-
graduate programs had granted almost 310,000 master’s degrees and 172,000 doctoral 
degrees. In areas related to enzyme technology (chemical engineering, science and food 
Fig. 1 Exports (gray), imports (white) and trade balance (black) including the thirty-one MCNs; a in terms of 
values (in millions of USD); and b in terms of amounts (in tons). The profile of both graphs showed no signifi-
cant difference when the three doubtful MCN codes were not considered (data not provided)
Fig. 2 Exports divided by total trade balance in USD (white) and exports divided by total trade balance in 
tons (black)
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technology, biochemistry, microbiology, pharmacy and chemistry), these numbers are 
14,285 and 17,660, respectively, corresponding to 5 and 10 % of the total (Figs. 3, 4).
Furthermore, Brazil’s participation in the global scientific production remarkably grew 
over the last 20 years. In 2009, Brazil occupied the 13th place in the international rank-
ing of scientific publications, surpassing countries such as Belgium and Denmark, which 
have more experience and tradition in the development of science (Almeida and Guima-
rães 2013). According to Almeida, the current performance of the country in producing 
science may be directly related to the expansion of the postgraduate system, which has 
been growing at a rate of 10 % per year in terms of new courses and number of master’s 
and doctoral degree holders.
By analyzing such data, it can be verified that Brazil has significant numbers con-
cerning the technical staff in enzyme technology correlated areas. Nevertheless, when 
considering the scientific production in enzyme technology by searching for accurate 
phrases associated to this field in researchers’ online curriculum, it can be observed 
that the numbers are lower than it could have been expected from the previous data. 
Although 10 % of the doctoral degree holders are included in areas related to enzyme 
Fig. 3 a Percentage of master’s degrees granted by Brazilian postgraduate programs in areas related to 
enzyme technology, b percentage distribution per area of the master’s degrees granted in areas related to 
enzyme technology
Fig. 4 a Percentage of doctoral degrees granted by Brazilian postgraduate programs in areas related to 
enzyme technology, b percentage distribution per area of the doctoral degrees granted in areas related to 
enzyme technology
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technology, a much smaller percentage is indeed producing knowledge in areas such as 
“enzyme technology”, “enzyme production”, “enzyme immobilization” and “enzymology” 
(Table 4).
Research community specialization
Table 5 shows a correlation of the MCN codes, each represented by a keyword, with the 
scientific production of Brazilian researchers in the enzyme technology field. The results 
of the search for “production of (keyword)” in the researchers’ online curriculum render 
clear the dominance of the Brazilian research on the so-called “enzyme commodities”, 
that is, large scale produced enzymes with low marked prices. Xylanase, amylase, pro-
tease, cellulase and lipase are enzymes that may be characterized as enzyme commodi-
ties. As commodities, these enzymes are used in detergents composition, food industry, 
bioenergy production (ethanol 2G and biodiesel), etc. Although it cannot be asserted 
that all researchers listed in Table 5 works in the areas they have been allotted, it is inter-
esting to observe that there is a correlation between the Brazilian economic structure, 
which is based on the production of commodities and low value-added goods, and the 
kind of enzymes most studied by the Brazilian researcher community. These data may 
suggest that economic specialization promotes a parallel specialization in the enzyme 
technology research community.
Bibliometric study
In order to access information regarding the type of work that has been realized by such 
scientific community, a bibliometric study related to scientific publications and patent 
documents was performed. Four industrial sectors that employ lipases were took into 
consideration—kinetic resolution, production of food and feed, detergent and biodiesel. 
Lipases were chosen as the enzyme model as they are one of the enzyme groups most 
researched by the Brazilian scientific community (Table 5).
Although the Brazilian contribution to the global scientific production is of 2.4 %, Bra-
zil accounts for only 0.2 % of the filings of patent applications, which is considered an 
important technical indicator (Em discussão! Revista de Audiências Públicas do Senado 
Federal 2012). As to enzyme technology, more specifically to lipases, the results of the 
present bibliometric study show that the Brazilian participation in the development and 
publication of scientific and patent follows the same pattern (Fig. 5).
In kinetic resolution, Brazil is in the eleventh position in the ranking of scientific pub-
lications, totaling 52 documents between 1983 and 2012; in the triennium of from 2010 
Table 4 Accurate phrases related to  the enzyme technology field searched in  the online 
curriculum of the researches
“Other researches” includes MSc, graduate and undergraduate students, and others
Accurate phrases DScs Other researchers
Enzyme technology 108 38
Enzyme production 566 481
Enzyme immobilization 206 65
Enzymology 345 143
Enzyme kinetics 276 93
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to 2012 Brazil occupied the second position in such ranking, only behind China. Never-
theless, Brazilian participation in the filing of patent applications is not as significant. No 
patent document found in the searches claims priority for a Brazilian document.
In production of food & feed, industrial sector that demands the greatest amount of 
enzymes in Brazil, 29  % in 2012 (Freedonia Group 2014), only one patent document 
claiming priority for a Brazilian document was found, which was filed by the Federal 
University of Minas Gerais and the company Phoneutria Biotecnologia e Serviços Ltda. 
On the other hand, Brazil ranks fifth in number of scientific documents published in this 
sector from 1983 to 2012, with 16 publications.
Table 5 Correlation of the MCN codes with the scientific production of Brazilian research-
ers
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Brazil is the fourth largest global market of cleaning products, and in 2012 had rev-
enues of 14.9 billion reais (ABIPLA 2013). In the searches for scientific documents pub-
lished by Brazilian research groups, only eight articles were detected in the period from 
1983 and 2012, five of which are authored by groups from the State University of Campi-
nas—UNICAMP). Moreover, despite the growing importance of the Brazilian market, 
only two patent documents have national applicants in the same period, one of them 
being co-assigned with Unilever N.V.
The Brazilian global participation as biodiesel consumer and producer is significant. 
In 2013, the country was the second largest consumer of such biofuel, with a demand of 
2.9 million m3. In the same year, the country ranks third in the production of biodiesel, 
yielding 3.0 million m3 (Ministério de Minas e Energia 2014). Brazil also stands out in 
studies related to biofuels. With specific respect to the scientific research related to the 
use of lipases for biodiesel production by enzymatic route, the country occupied the 
second global position up to 2012, with 52 publications. However, despite the country’s 
expressiveness in scientific publications directed to biodiesel production by transesteri-
fication involving lipases, only five patent documents, among the 165 documents found 
in the search, were filed by Brazilian applicants. It is noteworthy that the participation 
of Brazilian public universities in the filing of patent documents is more expressive than 
that of Brazilian companies.
The analysis of the publication countries of a given patent document can be used as an 
indication of the attractiveness of a country to foreign technologies. The results of the 
searches show that Brazil is not one of the most attractive countries to external tech-
nologies related to the industrial use of lipases (Fig. 6), the highest values being found 
in the detergent sector, wherein the country occupies the eighth position with almost 
20 % of the patents published in Brazil. Conversely, in the other sectors included in this 
study—kinetic resolution (nineteenth position), food and feed (thirteenth position) and 
biodiesel (ninth position)—Brazil is behind countries that have lower performance in 
scientific publication in the same sectors. In the case of kinetic resolution, for example, 
Brazil is behind countries like South Africa and Hungary.
Taking all data together, it can be assumed that the deficit in the Brazilian trade bal-
ance of enzyme-related goods is not entirely due to a lack of technical staff, since a con-
siderable number of DSc and MSc are formed every year in areas related to enzyme 
technology. However, taking into account the bibliometric study carried out, and 
Fig. 5 Percentage of scientific publications with Brazilian authors and patents with Brazilian applicants. 
Bibliometric studies realized from 1983 to 2012
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considering that the Brazilian contribution in the filing of patent documents is only mar-
ginal, it can be assumed that theses researchers have not been producing knowledge 
inside the productive sector (i.e. industries), but mainly in universities and governmental 
research centers. These results may be explained by the fact that only 42 % of the Brazil-
ian researches are employed in firms, while 79 % of North American researchers leave 
the university (Em discussão! Revista de Audiências Públicas do Senado Federal 2012). 
These findings can be related to the type of industrial production performed in Brazil, 
which is specialized in producing low-value added products, and to the low public and 
private investments in scientific researches.
In fact, an expanded look shows that trade deficit reaches the Brazilian trade bal-
ance as a whole, and is even greater for goods of the manufacturing industry (Instituto 
de Estudos para o Desenvolvimento Industrial 2014). Considering the classification 
according to technological intensity used by the Organization of Economic Co-opera-
tion and Development (OECD), it can be observed that Brazil is specialized in export-
ing low technological goods. On the other hand, Brazil’s imports are mainly constituted 
by goods with media-high and high technological intensity (Fig.  7). While imports of 
medium–high and high technological intensity goods totalize around 60 % of Brazilian 
overall trade balance, exports of this group of goods account only for 25–30 %. These 
numbers suggest a specialization in Brazilian industrial policy in favor of producing low 
value-added goods.
Brazilian Industrial Policy related to biotechnology
Although the development of the biotechnological field has been a priority of the Bra-
zilian government since 1970 (Ferrer et al. 2004), it seems that the different programs 
created ever since have not been effective in transforming the country into a reference 
in industrial biotechnology. It is only from 2004, with the Industrial and Technological 
and Foreign Trade Policy, that biotechnology has been considered as a “strategic field” 
(Bianchi 2013).
In 2007, the Brazilian government launched the Biotechnology Development Policy 
(Decree No. 6041), which, according to its first article, “aims to establish a suitable envi-
ronment for the development of innovative biotechnology products and processes”. It 
Fig. 6 Percentage of patents with publication in Brazil in comparison with all other countries. Bibliometric 
studies realized from 1983 to 2012
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has also created the Biotechnology National Committee, responsible for coordinating 
the implementation of the Biotechnology Development Policy.
The industrial policy currently in force is the Greater Brazil Plan, launched in 2011. In 
a document published in 2013 by the National Confederation of Industry called “Bio-
economy: an agenda for Brazil”, it is proposed the inclusion of biotechnology in the 
“Structuring Guideline 2—Expansion and creation of new technological and business 
skills”. Such inclusion would allow that all measures being taken in other sectors to boost 
investments were extended to biotechnology (Harvard Business Review Analytic Ser-
vices 2013).
Despite all these policies, the biotech sector in Brazil is yet weak, as it has been shown 
in 2011 by the Brazilian Biotechnology Association. The Brazil Biotech Map—2011 
(BRBiotec 2011) is a report about private companies in Brazilian territory. This report 
has showed that Brazil had 237 biotech companies; most of them being micro and small 
sized-companies. Among these companies, 56 % have annual revenues of no more than 
R$ 2.4 million (around 1.5 million dollars), 20 % have no revenues, and 85 % have up 
to 50 employees (20  % of them between 1 and 5 employees and 25 % of them having 
between 6 and 10). Furthermore, 25 % of the companies export, but on the other hand, 
86 % of them import especially reagents and equipment for the production and develop-
ment of technology.
Fig. 7 a Exports of products of the Manufacturing Industry by technological intensity and further products; 
and b imports of products of the Manufacturing Industry by technological intensity and further products 
Source: Letter IEDI n. 622, 2014
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Conclusion
The trade balance of enzyme-related goods in Brazil is negative, and despite the Bra-
zilian industrial policies and the Biotechnology Development Policy created in 2007, it 
has a tendency to become even more negative. The data presented herein suggests that 
Brazil has a sufficient technical staff. However, it does not means that the community 
research in enzyme technology is saturated. The major problem seems to be that the 
increase in the number of scientists is not accompanied by a proportional increase in the 
indicators of innovation in the country, which can also be observed in the bibliometric 
studies involving lipases, the most studied group of enzymes in Brazil. One other pos-
sible explanation for such disparity is the lack of demand by the Brazilian private firms.
On the other hand, when the entire Brazilian trade balance is analyzed, it is possible to 
conclude that the majority of Brazilian exports are composed of non-industrial or low-
technological goods. The loss of national industrial competitiveness is another result 
of the lack of innovation, which will not be overcome if additional public and private 
investments are not made in science and technology.
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